Datasheet is currently unavailable. Try again or CONTACT US
Human IgG (H&L) Antibody
Goat Polyclonal
4 References
609-1102
2 mg
Liquid (sterile filtered)
ELISA, Microarray
Human
Goat
Shipping info:
$50.00 to US & $70.00 to Canada for most products. Final costs are calculated at checkout.
Product Details
Goat Anti-Human IgG (H&L) Antibody - 609-1102
Human Antibody, Gt-a-Human IgG, Human Antibody in Goat, Human Secondary Antibody, Goat anti Human Antibody, Goat Anti-Human IgG Antibody
Goat
IgG (H&L)
Polyclonal
IgG
Target Details
Human
Native Protein
Anti-Human IgG whole molecule was produced by repeated immunization with Human IgG whole molecule in goat.
Anti-HUMAN IgG (H&L) (GOAT) Antibody was prepared from monospecific antiserum by immunoaffinity chromatography using Human IgG coupled to agarose. Anti-HUMAN IgG (H&L) (GOAT) Antibody Assay by immunoelectrophoresis resulted in a single precipitin arc against anti-Goat Serum, Human IgG and Human Serum.
Application Details
ELISA
Microarray
- View References
Anti-Human IgG has been tested by ELISA and is suitable for immunoblotting (western or dot blot), ELISA, immunoelectron microscopy and immunohistochemistry as well as other antibody based enzymatic assays requiring lot-to-lot consistency.
Formulation
2.2 mg/mL by UV absorbance at 280 nm
0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
0.01% (w/v) Sodium Azide
None
Shipping & Handling
Wet Ice
Store vial at 4° C prior to opening. This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use. For extended storage aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing.
Expiration date is one (1) year from date of receipt.
Anti-Human IgG (H&L) generated in goat detects human Immunoglobulin G (IgG), both heavy and light chains of the antibody molecule are present. It is a protein complex composed of four peptide chains — two identical heavy chains and two identical light chains arranged in a Y-shape typical of antibody monomers. Each IgG has two antigen binding sites. Representing approximately 75% of serum immunoglobulins in humans, IgG is the most abundant antibody isotype found in the circulation. IgG molecules are synthesized and secreted by plasma B cells. Secondary Antibodies are available in a variety of formats and conjugate types. When choosing a secondary antibody product, consideration must be given to species and immunoglobulin specificity, conjugate type, fragment and chain specificity, level of cross-reactivity, and host-species source and fragment composition.
Prabhakaran M et al. (2021). A sensitive method to quantify HIV-1 antibodies in mucosal samples. J immunol Methods.
Applications
E, EIA
Serrano-Coll, H et al. (2019). Social and environmental conditions related to Mycobacterium leprae infection in children and adolescents from three leprosy endemic regions of Colombia. Bmc Infectious Diseases
Applications
EIA, ELISA
Metz I, Beißbarth T, Ellenberger D, et al. (2016). Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis. Neurol Neuroimmunol Neuroinflamm.
Applications
Peptide Microarray
Bucukovski, J et al. (2015). A Multiplex Label-Free Approach to Avian Influenza Surveillance and Serology. PloS One
Applications
Microarray, Microarray chip
This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.
